{
    "Trade/Device Name(s)": [
        "MicroScan Synergies plus Gram-Positive MIC/Combo Panels with Levofloxacin"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K051311",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "JWY",
        "LRG",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "July 12, 2005",
    "Summary Letter Received Date": "May 24, 2005",
    "Submission Date": "May 13, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Levofloxacin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan Instrumentation",
        "WalkAway SI System",
        "Equivalent instruments"
    ],
    "Method(s)/Technology(ies)": [
        "Microdilution",
        "Dried Overnight Antimicrobial Susceptibility Testing (AST)"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Synergies plus Gram-Positive MIC/Combo Panels with Levofloxacin for antimicrobial susceptibility testing of gram-positive staphylococci and enterococci.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility, specifically for Levofloxacin, of colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-positive staphylococci and enterococci.",
    "fda_folder": "Microbiology"
}